Authors


Oliver Schacht, PhD

Latest:

Facing antibiotic-resistant “Superbugs” in the fight against COVID19

Rapid molecular diagnostic testing can be both clinically valuable and life-saving.


Vasilios Nassiopoulos

Latest:

2021 E&M Changes: Avoiding pitfalls with the right technology-enabled strategy

Extensive revisions aim to prioritize patient care information, resource-based reimbursement, and lessening the need for audits.


Sean McCloy, MD, MPH, MA

Latest:

Lyme Disease: In-office testing and clinical applications

Lockdown lifts are coinciding with the start of Lyme season.

© 2024 MJH Life Sciences

All rights reserved.